Bone and fat cross-talk in ART-treated HIV patients
Official title: Bone and fat cross-talk in antiretroviral therapy (ART) treated HIV patients
Funded at Rush University Medical Center · NIH-11560338 · Data updated 2026-11-12
Researchers are studying how bone health and fat changes interact in people with HIV on antiretroviral therapy to improve osteoporosis screening and monitoring.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rush University Medical Center NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | September 1, 2022 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $143,131 |
| NIH project number | 3R01AR081151-05S1 |
| Project ID | NIH-11560338 on NIH RePORTER |
Who could benefit from this research
✓Could help
Midlife women living with HIV and their primary HIV care providers, plus demographically similar women without HIV for comparison.
✕Less likely to help
People outside the study groups or those not considering bone health screening may not experience direct benefit.
What this research studies
If you have HIV and are aging, your bone health may be at higher risk for osteoporosis and fractures. This project will first explore what might prevent people with HIV and their healthcare providers from following osteoporosis screening guidelines, using surveys of midlife women with HIV and their doctors. It will also test a portable, radiation-free bone health screening device to track bone changes over time in women with HIV and similar women without HIV. The goal is to identify barriers and test a more accessible way to monitor bone loss so future care can be better tailored for people living with HIV.
Why it matters
Potential benefit: If successful, the study could lead to earlier, easier bone health screening and better prevention of osteoporosis for people with HIV.
How similar studies have gone: Prior work has shown barriers to osteoporosis screening exist; this project introduces a portable screening tool to monitor bone health, which is newer in this exact population.
Where this research is happening
-
Rush University Medical Center
Chicago, United States Active
Researchers
- Principal investigator: Ross, Ryan Dee — Rush University Medical Center
- Study coordinator: Ross, Ryan Dee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.